Methemoglobinemia: recognition and treatment
Cyanosis that does not respond to oxygen, a pulse oximeter stuck near 85%, and brown blood — plus what to do when the antidote fails.
Every clinical claim on this page is cited to its source below. How we source clinical content — including the corrections we have made and why.
A patient is cyanotic, the saturation will not come up on 100% oxygen, and the blood in the syringe looks brown. The diagnosis is usually straightforward once it is considered — and the reason it gets missed is that everything about the presentation looks like an airway or lung problem.
Key takeaways
- The signature is a saturation gap — pulse oximetry low while arterial saturation on blood gas is normal. A discrepancy above 5% should raise it.
- The pulse oximeter tends to stick near 85% and stays there regardless of oxygen, because methemoglobin absorbs light at both wavelengths.
- Diagnosis is co-oximetry, not a standard blood gas and not the pulse oximeter.
- Methylene blue 1–2 mg/kg IV over 5 minutes, with response usually within 20–30 minutes. Cumulative dose should not exceed 7 mg/kg — above that it becomes an oxidant itself.
- In G6PD deficiency methylene blue does not work and can cause severe hemolysis, because its mechanism depends on NADPH generated by G6PD. Ascorbic acid is the usual alternative.
- Rebound can occur up to 18 hours later with lipid-soluble agents such as benzocaine, so a single good response is not the end of the episode.
The mechanism, in one paragraph
Heme iron normally sits in the ferrous (Fe²⁺) state. When it is oxidized to ferric (Fe³⁺), that heme can no longer bind oxygen — and it also shifts the oxygen-dissociation curve leftward, so the remaining normal hemes release oxygen less readily.1 Erythrocytes normally hold methemoglobin below 1% using the methemoglobin reductase system. An oxidizing exposure that outpaces that system produces acquired methemoglobinemia.
Recognition
| Finding | Detail |
|---|---|
| Saturation gap | Pulse oximetry reads low while the calculated or measured arterial saturation is normal. A discrepancy greater than 5% between the two should raise suspicion2 |
| Refractory hypoxemia | Saturation remains in the 80% range despite supplementation, and does not improve with a non-rebreather3 |
| Fixed reading near 85% | The displayed saturation is often stuck around 85% and does not track clinical change1 |
| Chocolate-brown blood | Dark brown, and it does not turn red on exposure to air1,3 |
| Cyanosis unresponsive to oxygen | The clinical hallmark, and the one that separates it from most airway causes |
Why the oximeter behaves that way. A conventional two-wavelength pulse oximeter compares absorbance at 660 nm and 940 nm. Methemoglobin absorbs strongly at both, which drives the calculated ratio toward 1.0 — the ratio that corresponds to a displayed saturation of 85%. That happens as methemoglobin approaches roughly 30–35%.3 Above that the reading does not fall proportionally; it plateaus. So the number is not just wrong, it is uninformative in a specific and misleading way — and the level at which it stops being informative is the level at which the patient is getting sick.
Level and symptoms, roughly
Sources disagree on exact thresholds and none of this is strictly evidence-based, but the general shape:4
- Under 10% — often asymptomatic; cyanosis may appear above 5–10%
- 10–30% — cyanosis, fatigue, tachypnea, dyspnea, headache, anxiety
- 30–50% — confusion, chest pain, palpitations, marked distress
- Above 50% — dysrhythmia, seizure, coma
Symptoms also depend on total hemoglobin and cardiovascular reserve. An anemic patient tolerates a given methemoglobin fraction considerably worse.
Causes worth knowing in anesthesia
| Agent | Note |
|---|---|
| Benzocaine | Topical spray for endoscopy and transesophageal echo. Reported incidence during TEE ranges 0.067% to 0.45%. The FDA has required a standardized methemoglobinemia warning on benzocaine products since 2018. See TEE anesthesia, where the reaction is best documented |
| Prilocaine | Its metabolite o-toluidine is the oxidant — which is why the prilocaine maximum dose is set by methemoglobinemia rather than by LAST. See local anesthetic maximum doses |
| Nitrates and nitrites | Nitroglycerin, nitroprusside, amyl nitrite, sodium nitrite |
| Dapsone | Classic cause of recrudescent methemoglobinemia requiring repeated methylene blue doses5 |
| Other | Metoclopramide, phenazopyridine, rasburicase, sulfonamides, aniline dyes, and — at high doses — methylene blue itself4 |
Lidocaine is a much safer topical choice where the option exists: one institution reported no clinically evident cases across 3,354 transesophageal echocardiograms using lidocaine.
Treatment
First
Stop the offending agent. This is the single most important step. Give high-flow oxygen by non-rebreather — it will not change the pulse oximeter reading, but it increases dissolved oxygen delivery and supports natural degradation of methemoglobin.6
Methylene blue
| Dose | 1–2 mg/kg IV over 5 minutes (0.1–0.2 mL/kg of a 1% solution)2,3,7 |
| Onset | Improvement usually within 20–30 minutes; one dose suffices in most patients5,6 |
| Repeat | May repeat after 30–60 minutes if the level remains elevated3,5,6 |
| Ceiling | Cumulative dose should not exceed 7 mg/kg. Above that methylene blue is itself an oxidant and can cause methemoglobinemia and hemolysis5,8 |
| Threshold to treat | Commonly cited at methemoglobin above 20–30%, or lower where the patient is symptomatic or has limited reserve4 |
Three side effects that matter intraoperatively
- Methylene blue makes the pulse oximeter read low. Its presence in blood underestimates saturation by pulse oximetry — so obtain an arterial sample if you need a real number during or shortly after the infusion.9
- It drops the BIS. A fall in Bispectral Index has been reported after methylene blue; if it is given during surgery, use another method to assess anesthetic depth.9
- It is a monoamine oxidase inhibitor and may precipitate serotonin toxicity in patients on serotonergic agents.3
When methylene blue does not work
This is the section worth reading before you need it. Methylene blue works by donating electrons through NADPH-dependent methemoglobin reductase — and that NADPH is generated by G6PD in the hexose monophosphate shunt.3 In G6PD deficiency the pathway cannot run, so the drug is ineffective, and its own oxidant properties then act unopposed: severe hemolysis and severe anemia have been reported.9
In one reported case, methylene blue given before the deficiency was known drove hemoglobin from 81 g/L down to 38 g/L; it was stopped and replaced with vitamin C.10 About 2% of the US population has G6PD deficiency, and there is no recommendation for routine testing before treatment8 — so this is a diagnosis you will usually make from the failure to respond.
The differential when it fails
- G6PD deficiency — most common reason. Switch to ascorbic acid; doses used range widely, and reported regimens include roughly 1.5–3 g IV every 6 hours in adults.4 Exchange transfusion and hyperbaric oxygen are second-line.8
- Sulfhemoglobinemia — conventional co-oximetry misidentifies sulfhemoglobin as methemoglobin, so non-response to methylene blue is how the diagnosis is usually suspected. It typically requires no treatment beyond removing the offending agent.2
- Hemoglobin M — a structural variant; methylene blue is ineffective.8
- Ongoing exposure — the agent has not actually been stopped, or is still being absorbed.
- Too much methylene blue — above 7 mg/kg cumulative it becomes the oxidant.5
One nuance worth carrying, because it is frequently stated backwards. The G6PD connection has led to a common misconception that G6PD deficiency is itself a risk factor for developing methemoglobinemia — a belief the source literature names explicitly as a misconception.3 Under normal conditions the NADPH pathway contributes minimally to methemoglobin reduction; it matters mainly as the route methylene blue exploits. G6PD deficiency is primarily a problem for the treatment, not the susceptibility.
Rebound
Recrudescent methemoglobinemia can occur within 18 hours as lipid-soluble agents such as benzocaine are slowly released from tissue stores,1 and dapsone is the classic cause of a second rise requiring repeated dosing.5 A patient who responds well should still have a repeat co-oximetry several hours later rather than being signed off on the initial improvement.
Frequently asked questions
What is a saturation gap?
The difference between the oxygen saturation displayed by the pulse oximeter and the saturation measured or calculated from an arterial blood gas. In methemoglobinemia the pulse oximeter reads low while the blood gas reads normal; a discrepancy greater than 5% should raise suspicion.2
Why does the pulse oximeter read about 85% in methemoglobinemia?
Because methemoglobin absorbs light strongly at both wavelengths a conventional oximeter uses, driving the absorbance ratio toward 1.0 — the value that corresponds to a displayed saturation of 85%. That point is reached as methemoglobin approaches 30–35%, and the reading then becomes fixed near that number and stops tracking the actual level, so the value is not merely inaccurate but uninformative.1,3
What is the dose of methylene blue for methemoglobinemia?
1–2 mg/kg intravenously over 5 minutes, with response usually within 20 to 30 minutes.2,7 It may be repeated if the level remains elevated. The cumulative dose should not exceed 7 mg/kg, because above that methylene blue acts as an oxidant and can itself cause methemoglobinemia and hemolysis.5,8
Can you give methylene blue in G6PD deficiency?
No. Methylene blue works through an NADPH-dependent pathway that requires G6PD, so it is ineffective — and its own oxidant properties can then cause severe hemolysis and anemia.3,9 Ascorbic acid is the usual alternative, with exchange transfusion and hyperbaric oxygen as further options.8
What if methylene blue does not work?
Consider G6PD deficiency first, then sulfhemoglobinemia — which conventional co-oximetry misreads as methemoglobin and which is typically suspected precisely because of non-response.2 Also consider hemoglobin M, continued exposure to the offending agent, and cumulative methylene blue above 7 mg/kg.5,8
Which anesthetic drugs cause methemoglobinemia?
Benzocaine and prilocaine are the two that matter most in anesthesia — prilocaine’s maximum dose is set by methemoglobinemia rather than by systemic toxicity. Nitroglycerin, nitroprusside, nitrites, dapsone, metoclopramide and phenazopyridine are others.4 Lidocaine is a substantially safer topical alternative to benzocaine.
References
- Methemoglobinemia. OpenAnesthesia. Covers the ferrous-to-ferric mechanism, the leftward shift of the oxygen-dissociation curve, causative agents including prilocaine and benzocaine, and rebound within 18 hours from lipid-soluble agents.
- Methemoglobinemia. WikEM. Methylene blue 1–2 mg/kg over 5 minutes with improvement within 20 minutes; saturation gap greater than 5%; sulfhemoglobin misidentified by conventional co-oximetry.
- Methemoglobinemia. StatPearls, NCBI Bookshelf, updated December 2025. Bookshelf ID NBK537317. Methylene blue 1–2 mg/kg (0.1–0.2 mL/kg of 1% solution) IV over 5 minutes, repeatable after 30–60 minutes; absorbance ratio reaches 1.0 at a methemoglobin of 30–35%, corresponding to a displayed SpO₂ of 85%; saturation gap greater than 5%; the NADPH-MetHb reductase pathway and its dependence on G6PD; the explicit statement that G6PD deficiency being a risk factor for methemoglobinemia is a misconception; and the monoamine oxidase inhibitor property of methylene blue.
- Methemoglobinemia. EMCrit Internet Book of Critical Care. Level-symptom ranges with the caveat that sources disagree, the causative agent list, and ascorbic acid dosing.
- Methemoglobinemia. ScienceDirect topic overview. Cumulative methylene blue ceiling of 7 mg/kg, response within 30 minutes, and recrudescent methemoglobinemia with dapsone.
- Methemoglobinemia: when to suspect and how to treat. Curr Med Issues. doi:10.4103/cmi.cmi_55_19. Supportive care, repeat dosing after 1 hour if methemoglobin remains above 20%.
- Methylene blue 1–2 mg/kg IV over five minutes, as specified in clinical protocol documentation, with the note that methylene blue is contraindicated in G6PD deficiency because its action as an electron carrier depends on NADPH generated by G6PD through the hexose monophosphate shunt.
- Methemoglobinemia treatment and management. Medscape. Notes methylene blue ineffectiveness in G6PD deficiency and hemoglobin M, the approximately 2% US prevalence of G6PD deficiency with no routine testing recommendation, and second-line options.
- ProvayBlue (methylene blue) prescribing information. Contraindicated in G6PD deficiency; hemolytic anemia with onset possibly delayed a day or more; pulse oximetry underestimation; reported fall in Bispectral Index.
- Chen B, Han Y. Co-occurrence of acute hemolytic anemia and methemoglobinemia in a 74-year-old female with G6PD deficiency: a case report. Medicine (Baltimore). 2025. doi:10.1097/MD.0000000000042826. Hemoglobin fell from 81 to 38 g/L after methylene blue; replaced with vitamin C and methylprednisolone.
Disclaimer. Reference information for licensed clinicians and students. Not a medical device, and not a substitute for clinical judgment. Verify against your institutional protocol and current package inserts.
The LAST checklist, local anesthetic ceilings and this differential ship inside Helix Anesthesia — a point-of-care reference built by a practicing CRNA, cited and available offline. See how we source clinical content.
Built for the anesthesia machine, not the desk. It opens in one tap, works with no signal in an OR that has none, and shows the citation on screen beside the number rather than making you go and find it.
Free tier, no card: every calculator, every crisis checklist, the full drug library and glossary, three complete regional blocks, five complete surgical cases, and 15 AI questions a month.
Get Helix Anesthesia How we source itLocal anesthetic and sedation safety
- Local anesthetic maximum doses — start here
- TEE anesthesia
Preparing for surgery yourself? What to tell your anesthesia provider — the plain-language version. · All clinical answers